1. Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study
- Author
-
Kallieri, Maria, primary, Papaioannou, Andriana I., additional, Zervas, Eleftherios, additional, Fouka, Evangelia, additional, Porpodis, Konstantinos, additional, Hadji Mitrova, Marija, additional, Tzortzaki, Eleni, additional, Makris, Michael, additional, Ntakoula, Maria, additional, Lyberopoulos, Panagiotis, additional, Dimakou, Katerina, additional, Koukidou, Sofia, additional, Ampelioti, Sevasti, additional, Papaporfyriou, Anastasia, additional, Katsoulis, Konstantinos, additional, Kipourou, Maria, additional, Rovina, Nikoletta, additional, Antoniou, Katerina, additional, Vittorakis, Stylianos, additional, Bakakos, Petros, additional, Steiropoulos, Paschalis, additional, Markopoulou, Katerina, additional, Avarlis, Panteleimon, additional, Papanikolaou, Ιlias C., additional, Markatos, Miltiadis, additional, Gaki, Eleni, additional, Samitas, Konstantinos, additional, Glynos, Konstantinos, additional, Papiris, Spyros A., additional, Papakosta, Despoina, additional, Tzanakis, Nikolaos, additional, Gaga, Mina, additional, Kostikas, Konstantinos, additional, and Loukides, Stelios, additional
- Published
- 2023
- Full Text
- View/download PDF